Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine as an adjuvant to paravertebral block for analgesia after thoracoscopic surgery
ChiCTR2100053589Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and ropivacaine in postoperative pain (3 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Sufentanil dosage within 48 hours after extubation. Started Mar 2022; status: recruiting.
02
Drugs
esketamineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100053589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053589.